Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens
Patent
·
OSTI ID:1019397
- Los Alamos, NM
- Durham, NC
- Boston, MA
- Birmingham, AL
The present invention relates to mosaic clade M HIV-1 Env polypeptides and to compositions comprising same. The polypeptides of the invention are suitable for use in inducing an immune response to HIV-1 in a human.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-06NA25396
- Assignee:
- Los Alamos National Security, LLC (Los Alamos, NM); Duke University (Durham, NC); Beth Isreal Deaconess Medical Center (Boston, MA); The University of Albama at Birmingham Research Foundation (Birmingham, AL)
- Patent Number(s):
- 7,951,377
- Application Number:
- 12/192,015
- OSTI ID:
- 1019397
- Country of Publication:
- United States
- Language:
- English
Polygene DNA vaccine induces a high level of protective effect against HIV-vaccinia virus challenge in mice
|
journal | September 2004 |
Similar Records
Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens
Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins
Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins
Patent
·
Tue Apr 21 00:00:00 EDT 2015
·
OSTI ID:1019397
+3 more
Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins
Patent
·
Tue Nov 21 00:00:00 EST 2017
·
OSTI ID:1019397
+3 more
Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins
Patent
·
Tue Feb 21 00:00:00 EST 2012
·
OSTI ID:1019397
+7 more